![Segmental vitiligo: A randomized controlled trial to evaluate efficacy and safety of 0.1% tacrolimus ointment vs 0.05% fluticasone propionate cream - Indian Journal of Dermatology, Venereology and Leprology Segmental vitiligo: A randomized controlled trial to evaluate efficacy and safety of 0.1% tacrolimus ointment vs 0.05% fluticasone propionate cream - Indian Journal of Dermatology, Venereology and Leprology](https://ijdvl.com/content/126/2012/78/1/Images/ijdvl_2012_78_1_68_90949_f8.jpg)
Segmental vitiligo: A randomized controlled trial to evaluate efficacy and safety of 0.1% tacrolimus ointment vs 0.05% fluticasone propionate cream - Indian Journal of Dermatology, Venereology and Leprology
![A combination of excimer laser treatment and topical tacrolimus is more effective in treating vitiligo than either therapy alone for the initial 6 months, but not thereafter - Park - 2016 - A combination of excimer laser treatment and topical tacrolimus is more effective in treating vitiligo than either therapy alone for the initial 6 months, but not thereafter - Park - 2016 -](https://onlinelibrary.wiley.com/cms/asset/bc408870-ce96-428c-96cd-9056b31c9e33/ced12742-fig-0001-m.jpg)
A combination of excimer laser treatment and topical tacrolimus is more effective in treating vitiligo than either therapy alone for the initial 6 months, but not thereafter - Park - 2016 -
![Segmental vitiligo: A randomized controlled trial to evaluate efficacy and safety of 0.1% tacrolimus ointment vs 0.05% fluticasone propionate cream - Indian Journal of Dermatology, Venereology and Leprology Segmental vitiligo: A randomized controlled trial to evaluate efficacy and safety of 0.1% tacrolimus ointment vs 0.05% fluticasone propionate cream - Indian Journal of Dermatology, Venereology and Leprology](https://ijdvl.com/content/126/2012/78/1/Images/ijdvl_2012_78_1_68_90949_f9.jpg)
Segmental vitiligo: A randomized controlled trial to evaluate efficacy and safety of 0.1% tacrolimus ointment vs 0.05% fluticasone propionate cream - Indian Journal of Dermatology, Venereology and Leprology
![Treatment Outcomes of Topical Calcineurin Inhibitor Therapy for Patients With Vitiligo | PracticeUpdate Treatment Outcomes of Topical Calcineurin Inhibitor Therapy for Patients With Vitiligo | PracticeUpdate](https://d2ogjlfjkptkow.cloudfront.net/contentimage/21400.jpg)
Treatment Outcomes of Topical Calcineurin Inhibitor Therapy for Patients With Vitiligo | PracticeUpdate
![Triple Combination of Systemic Corticosteroids, Excimer Laser, and Topical Tacrolimus in the Treatment of Recently Developed Localized Vitiligo Triple Combination of Systemic Corticosteroids, Excimer Laser, and Topical Tacrolimus in the Treatment of Recently Developed Localized Vitiligo](https://anndermatol.org/ArticleImage/0140AD/ad-27-104-g001-l.jpg)
Triple Combination of Systemic Corticosteroids, Excimer Laser, and Topical Tacrolimus in the Treatment of Recently Developed Localized Vitiligo
![Safety and Efficacy of the Combination of 308-nm Monochromatic Excimer Light and Topical 0.1% Tacrolimus Ointment in Segmental Vitiligo: An Open-label Study. - Abstract - Europe PMC Safety and Efficacy of the Combination of 308-nm Monochromatic Excimer Light and Topical 0.1% Tacrolimus Ointment in Segmental Vitiligo: An Open-label Study. - Abstract - Europe PMC](https://europepmc.org/articles/PMC7158913/bin/jcad_13_2_E69_g004.jpg)
Safety and Efficacy of the Combination of 308-nm Monochromatic Excimer Light and Topical 0.1% Tacrolimus Ointment in Segmental Vitiligo: An Open-label Study. - Abstract - Europe PMC
![Safety and Efficacy of the Combination of 308-nm Monochromatic Excimer Light and Topical 0.1% Tacrolimus Ointment in Segmental Vitiligo: An Open-label Study • Aerolase Safety and Efficacy of the Combination of 308-nm Monochromatic Excimer Light and Topical 0.1% Tacrolimus Ointment in Segmental Vitiligo: An Open-label Study • Aerolase](https://aerolase.com/wp-content/uploads/2022/08/Figure-11-vitiligo-200x223.png)
Safety and Efficacy of the Combination of 308-nm Monochromatic Excimer Light and Topical 0.1% Tacrolimus Ointment in Segmental Vitiligo: An Open-label Study • Aerolase
![Topical tacrolimus therapy for vitiligo: therapeutic responses and skin messenger RNA expression of proinflammatory cytokines - ScienceDirect Topical tacrolimus therapy for vitiligo: therapeutic responses and skin messenger RNA expression of proinflammatory cytokines - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0190962204005171-gr3.jpg)
Topical tacrolimus therapy for vitiligo: therapeutic responses and skin messenger RNA expression of proinflammatory cytokines - ScienceDirect
![Tacrolimus ointment promotes repigmentation of vitiligo in children: A review of 57 cases - ScienceDirect Tacrolimus ointment promotes repigmentation of vitiligo in children: A review of 57 cases - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0190962204015774-gr2.jpg)
Tacrolimus ointment promotes repigmentation of vitiligo in children: A review of 57 cases - ScienceDirect
![Tacrolimus ointment helps restore pigment in facial vitiligo | Latest news for Doctors, Nurses and Pharmacists | Dermatology Tacrolimus ointment helps restore pigment in facial vitiligo | Latest news for Doctors, Nurses and Pharmacists | Dermatology](https://pubmiddleware.mims.com/resource/image/63E9831B-1440-4FFD-8968-ACCB00343E2A/OriginalThumbnail/THUMBNAIL_shutterstock_1080517253.jpg)
Tacrolimus ointment helps restore pigment in facial vitiligo | Latest news for Doctors, Nurses and Pharmacists | Dermatology
![Utility of dermoscopy for evaluating the therapeutic efficacy of tacrolimus ointment plus 308-nm excimer laser combination therapy in localized vitiligo patients Utility of dermoscopy for evaluating the therapeutic efficacy of tacrolimus ointment plus 308-nm excimer laser combination therapy in localized vitiligo patients](https://www.spandidos-publications.com/article_images/etm/15/4/etm-15-04-3981-g00.jpg)
Utility of dermoscopy for evaluating the therapeutic efficacy of tacrolimus ointment plus 308-nm excimer laser combination therapy in localized vitiligo patients
![Occlusive treatment enhances efficacy of tacrolimus 0.1% ointment in adult patients with vitiligo: results of a placebo-controlled 12-month prospective study. | Semantic Scholar Occlusive treatment enhances efficacy of tacrolimus 0.1% ointment in adult patients with vitiligo: results of a placebo-controlled 12-month prospective study. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/c7ed106daea85c41a6a62946e103560347fe2317/3-Figure1-1.png)
Occlusive treatment enhances efficacy of tacrolimus 0.1% ointment in adult patients with vitiligo: results of a placebo-controlled 12-month prospective study. | Semantic Scholar
![Safety and Efficacy of the Combination of 308-nm Monochromatic Excimer Light and Topical 0.1% Tacrolimus Ointment in Segmental Vitiligo: An Open-label Study | JCAD | The Journal of Clinical and Aesthetic Dermatology Safety and Efficacy of the Combination of 308-nm Monochromatic Excimer Light and Topical 0.1% Tacrolimus Ointment in Segmental Vitiligo: An Open-label Study | JCAD | The Journal of Clinical and Aesthetic Dermatology](https://bwcbuildout.com/jcad/wp-content/uploads/ShahFeb2020Figure1.jpg)